ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.verified

ACAD

Price:

$14.84

Market Cap:

$2.45B

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for...[Read more]

Industry

Biotechnology

IPO Date

2004-05-27

Stock Exchange

NASDAQ

Ticker

ACAD

The PE Ratio as of June 2024 (TTM) for ACADIA Pharmaceuticals Inc. (ACAD) is -40.11

According to ACADIA Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -40.11. This represents a change of -117.09% compared to the average of 234.76 of the last 4 quarters.

ACADIA Pharmaceuticals Inc. (ACAD) Historical PE Ratio (quarterly & annually)

How has ACAD PE Ratio performed in the past?

The mean historical PE Ratio of ACADIA Pharmaceuticals Inc. over the last ten years is -26.32. The current -40.11 PE Ratio has changed 15.14% with respect to the historical average. Over the past ten years (40 quarters), ACAD's PE Ratio was at its highest in in the June 2023 quarter at 878.55. The PE Ratio was at its lowest in in the September 2021 quarter at -46.15.

Quarterly (TTM)
Annual

Average

-26.32

Median

-22.07

Minimum

-83.69

Maximum

-8.35

ACADIA Pharmaceuticals Inc. (ACAD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ACADIA Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 602.23%

Maximum Annual PE Ratio = -8.35

Minimum Annual Increase = -46.59%

Minimum Annual PE Ratio = -83.69

Quarterly (TTM)
Annual
YearPE RatioChange
2023-83.69602.23%
2022-11.92-46.59%
2021-22.31-25.30%
2020-29.8711.59%
2019-26.77220.64%
2018-8.35-34.55%
2017-12.763.60%
2016-12.31-43.56%
2015-21.82-34.66%
2014-33.39-40.85%

ACADIA Pharmaceuticals Inc. (ACAD) Average PE Ratio

How has ACAD PE Ratio performed in the past?

The current PE Ratio of ACADIA Pharmaceuticals Inc. (ACAD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-39.31

5-year avg

-34.91

10-year avg

-26.32

ACADIA Pharmaceuticals Inc. (ACAD) PE Ratio vs. Peers

How is ACAD’s PE Ratio compared to its peers?

ACADIA Pharmaceuticals Inc.’s PE Ratio is less than Madrigal Pharmaceuticals, Inc. (-12.46), greater than Viking Therapeutics, Inc. (-57.42), less than Sarepta Therapeutics, Inc. (649.88), less than Hepion Pharmaceuticals, Inc. (-0.14), less than PTC Therapeutics, Inc. (-4.68), less than Reviva Pharmaceuticals Holdings, Inc. (-0.93), less than Athira Pharma, Inc. (-0.86), less than Fortress Biotech, Inc. (-0.57), less than Cabaletta Bio, Inc. (-6.00), less than Intercept Pharmaceuticals, Inc. (-13.55), less than Terns Pharmaceuticals, Inc. (-6.50), less than Akero Therapeutics, Inc. (-7.58), greater than Reata Pharmaceuticals, Inc. (-89.36), less than Krystal Biotech, Inc. (87.97), less than Blueprint Medicines Corporation (-22.19),

Build a custom stock screener for ACADIA Pharmaceuticals Inc. (ACAD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ACADIA Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ACADIA Pharmaceuticals Inc. (ACAD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ACADIA Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is ACADIA Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for ACADIA Pharmaceuticals Inc. (ACAD)?

What is the highest PE Ratio for ACADIA Pharmaceuticals Inc. (ACAD)?

What is the 3-year average PE Ratio for ACADIA Pharmaceuticals Inc. (ACAD)?

What is the 5-year average PE Ratio for ACADIA Pharmaceuticals Inc. (ACAD)?

How does the current PE Ratio for ACADIA Pharmaceuticals Inc. (ACAD) compare to its historical average?